Natco Pharma has informed that the meeting of the Board of Directors of the Company is scheduled to be held on November 11, 2016, to consider the Unaudited Financial Results for the quarter and half year ended September 30, 2016, and related matters (Q2). Further note that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 Trading Window for dealing in the securities of the Company will be closed from November 01, 2016 to November 13, 2016. Trading window will be opened from November 14, 2016.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: